| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 高血压类药(元) | 205,242,761.41 | 102,779,572.49 | 137,174,779.76 | 71,157,879.36 |
| 泌尿系统类(元) | 421,383.16 | 245,313.52 | 257,654.08 | 113,833.63 |
| 糖尿病类药(元) | 499,341,715.25 | 257,502,787.18 | 494,203,570.06 | 236,964,858.96 |
| 周围神经类药(元) | 2,643,704.51 | 1,130,872.20 | 3,025,159.87 | 1,623,969.88 |
| 罕见病类药(元) | 1,558,190.41 | 708,213.02 | 385,852.60 | 19,526.55 |
| 其他主营业务(元) | - | - | - | 19,526.55 |
| 营业成本(元) | ||||
| 高血压类药(元) | 13,021,643.20 | 6,884,515.78 | 10,248,175.34 | 5,549,511.46 |
| 泌尿系统类(元) | 89,371.40 | 43,615.80 | 41,443.10 | 17,136.98 |
| 糖尿病类药(元) | 114,146,850.26 | 57,047,850.05 | 114,775,756.34 | 52,632,368.40 |
| 周围神经类药(元) | 1,269,940.53 | 565,314.77 | 1,457,699.61 | 797,717.52 |
| 罕见病类药(元) | 50,689.91 | 20,774.12 | 15,218.26 | 261.06 |
| 其他主营业务(元) | - | - | - | 261.06 |
| 毛利(元) | ||||
| 高血压类药(元) | 192,221,118.21 | 95,895,056.71 | 126,926,604.42 | 65,608,367.90 |
| 泌尿系统类(元) | 332,011.76 | 201,697.72 | 216,210.98 | 96,696.65 |
| 糖尿病类药(元) | 385,194,864.99 | 200,454,937.13 | 379,427,813.72 | 184,332,490.56 |
| 周围神经类药(元) | 1,373,763.98 | 565,557.43 | 1,567,460.26 | 826,252.36 |
| 罕见病类药(元) | 1,507,500.50 | 687,438.90 | 370,634.34 | 19,265.49 |
| 其他主营业务(元) | - | - | - | 19,265.49 |
| 毛利率(%) | ||||
| 高血压类药(%) | 93.66 | 93.30 | 92.53 | 92.20 |
| 泌尿系统类(%) | 78.79 | 82.22 | 83.92 | 84.95 |
| 糖尿病类药(%) | 77.14 | 77.85 | 76.78 | 77.79 |
| 周围神经类药(%) | 51.96 | 50.01 | 51.81 | 50.88 |
| 罕见病类药(%) | 96.75 | 97.07 | 96.06 | 98.66 |
| 其他主营业务(%) | - | - | - | 98.66 |
| 收入构成(%) | ||||
| 高血压类药(%) | 28.94 | 28.36 | 21.60 | 22.96 |
| 泌尿系统类(%) | 0.06 | 0.07 | 0.04 | 0.04 |
| 糖尿病类药(%) | 70.41 | 71.06 | 77.82 | 76.47 |
| 周围神经类药(%) | 0.37 | 0.31 | 0.48 | 0.52 |
| 罕见病类药(%) | 0.22 | 0.20 | 0.06 | 0.01 |
| 其他主营业务(%) | - | - | - | 0.01 |
| 毛利构成(%) | ||||
| 高血压类药(%) | 33.11 | 32.20 | 24.96 | 26.15 |
| 泌尿系统类(%) | 0.06 | 0.07 | 0.04 | 0.04 |
| 糖尿病类药(%) | 66.34 | 67.31 | 74.62 | 73.47 |
| 周围神经类药(%) | 0.24 | 0.19 | 0.31 | 0.33 |
| 罕见病类药(%) | 0.26 | 0.23 | 0.07 | 0.01 |
| 其他主营业务(%) | - | - | - | 0.01 |